Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study
Titel:
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study
Auteur:
Calvaruso, Vincenza Petta, Salvatore Ferraro, Donatella La Mantia, Claudia Gibilaro, Gerlando Reina, Giada Di Maio, Velia Chiara Licata, Anna Ceccherini-Silberstein, Francesca Di Marco, Vito Craxì, Antonio